Thyroidectomy remains an effective treatment option for Graves’ disease: reply
Seven of our patients received postoperative radioiodine, 5 with a diagnosis of cancer and 2 with a diagnosis of ophthalmopathy. Because most of these patients are referred to us by an endocrinologist, some of the decision making about further radioiodine therapy reverts back to them because they pr...
Gespeichert in:
Veröffentlicht in: | The American journal of surgery 2007-08, Vol.194 (2), p.270-271 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 271 |
---|---|
container_issue | 2 |
container_start_page | 270 |
container_title | The American journal of surgery |
container_volume | 194 |
creator | Weber, Kaare J., M.D Solorzano, Carmen C., M.D Lee, Jane K., M.D Gaffud, Michael J., M.D Prinz, Richard A., M.D |
description | Seven of our patients received postoperative radioiodine, 5 with a diagnosis of cancer and 2 with a diagnosis of ophthalmopathy. Because most of these patients are referred to us by an endocrinologist, some of the decision making about further radioiodine therapy reverts back to them because they provide ongoing follow-up evaluation and management. |
doi_str_mv | 10.1016/j.amjsurg.2006.07.021 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1444609479</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002961007001468</els_id><sourcerecordid>3107756081</sourcerecordid><originalsourceid>FETCH-LOGICAL-c340t-8ecbe8e3de5d6651242b1557de946f01aa4d31d5de0e1ed4962acfb0ae9db3f23</originalsourceid><addsrcrecordid>eNqFkdFKwzAUhoMoOKePIBS8bj1p07T1QhHRKQwUnNchS041dW1m0g1652v4ej6JGRsI3nh1yOH__yTfT8gphYQC5edNItvGr9xrkgLwBIoEUrpHRrQsqpiWZbZPRgCQxhWncEiOvG_CkVKWjcjT7G1w1mhUvW2HyGErTecj2UVY12Fp1hj1DmXfYtdHdtkb20W1ddHEyTX678-vSBuP0uNFMC8XwzE5qOXC48lujsnL3e3s5j6ePk4ebq6nscoY9HGJao4lZhpzzXlOU5bOaZ4XGivGa6BSMp1RnWsEpKhZxVOp6jlIrPQ8q9NsTM62uUtnP1boe9HYlevClYIyxjhUrKiCKt-qlLPeO6zF0plWukFQEBt4ohE7eGIDT0AhArzgu9r6MHxhbdAJrwx2CrVxgYrQ1vybcPknQS1MZ5RcvOOA_vexwqcCxPOmoE0_UIRqGC-zH-0Skh8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1444609479</pqid></control><display><type>article</type><title>Thyroidectomy remains an effective treatment option for Graves’ disease: reply</title><source>Elsevier ScienceDirect Journals</source><creator>Weber, Kaare J., M.D ; Solorzano, Carmen C., M.D ; Lee, Jane K., M.D ; Gaffud, Michael J., M.D ; Prinz, Richard A., M.D</creator><creatorcontrib>Weber, Kaare J., M.D ; Solorzano, Carmen C., M.D ; Lee, Jane K., M.D ; Gaffud, Michael J., M.D ; Prinz, Richard A., M.D</creatorcontrib><description>Seven of our patients received postoperative radioiodine, 5 with a diagnosis of cancer and 2 with a diagnosis of ophthalmopathy. Because most of these patients are referred to us by an endocrinologist, some of the decision making about further radioiodine therapy reverts back to them because they provide ongoing follow-up evaluation and management.</description><identifier>ISSN: 0002-9610</identifier><identifier>EISSN: 1879-1883</identifier><identifier>DOI: 10.1016/j.amjsurg.2006.07.021</identifier><language>eng</language><publisher>New York: Elsevier Inc</publisher><subject>Cancer therapies ; Hormones ; Immune system ; Patients ; Surgery ; Thyroid cancer</subject><ispartof>The American journal of surgery, 2007-08, Vol.194 (2), p.270-271</ispartof><rights>Excerpta Medica Inc.</rights><rights>2007 Excerpta Medica Inc.</rights><rights>Copyright Elsevier Limited Aug 2007</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0002961007001468$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids></links><search><creatorcontrib>Weber, Kaare J., M.D</creatorcontrib><creatorcontrib>Solorzano, Carmen C., M.D</creatorcontrib><creatorcontrib>Lee, Jane K., M.D</creatorcontrib><creatorcontrib>Gaffud, Michael J., M.D</creatorcontrib><creatorcontrib>Prinz, Richard A., M.D</creatorcontrib><title>Thyroidectomy remains an effective treatment option for Graves’ disease: reply</title><title>The American journal of surgery</title><description>Seven of our patients received postoperative radioiodine, 5 with a diagnosis of cancer and 2 with a diagnosis of ophthalmopathy. Because most of these patients are referred to us by an endocrinologist, some of the decision making about further radioiodine therapy reverts back to them because they provide ongoing follow-up evaluation and management.</description><subject>Cancer therapies</subject><subject>Hormones</subject><subject>Immune system</subject><subject>Patients</subject><subject>Surgery</subject><subject>Thyroid cancer</subject><issn>0002-9610</issn><issn>1879-1883</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkdFKwzAUhoMoOKePIBS8bj1p07T1QhHRKQwUnNchS041dW1m0g1652v4ej6JGRsI3nh1yOH__yTfT8gphYQC5edNItvGr9xrkgLwBIoEUrpHRrQsqpiWZbZPRgCQxhWncEiOvG_CkVKWjcjT7G1w1mhUvW2HyGErTecj2UVY12Fp1hj1DmXfYtdHdtkb20W1ddHEyTX678-vSBuP0uNFMC8XwzE5qOXC48lujsnL3e3s5j6ePk4ebq6nscoY9HGJao4lZhpzzXlOU5bOaZ4XGivGa6BSMp1RnWsEpKhZxVOp6jlIrPQ8q9NsTM62uUtnP1boe9HYlevClYIyxjhUrKiCKt-qlLPeO6zF0plWukFQEBt4ohE7eGIDT0AhArzgu9r6MHxhbdAJrwx2CrVxgYrQ1vybcPknQS1MZ5RcvOOA_vexwqcCxPOmoE0_UIRqGC-zH-0Skh8</recordid><startdate>20070801</startdate><enddate>20070801</enddate><creator>Weber, Kaare J., M.D</creator><creator>Solorzano, Carmen C., M.D</creator><creator>Lee, Jane K., M.D</creator><creator>Gaffud, Michael J., M.D</creator><creator>Prinz, Richard A., M.D</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>20070801</creationdate><title>Thyroidectomy remains an effective treatment option for Graves’ disease: reply</title><author>Weber, Kaare J., M.D ; Solorzano, Carmen C., M.D ; Lee, Jane K., M.D ; Gaffud, Michael J., M.D ; Prinz, Richard A., M.D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c340t-8ecbe8e3de5d6651242b1557de946f01aa4d31d5de0e1ed4962acfb0ae9db3f23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Cancer therapies</topic><topic>Hormones</topic><topic>Immune system</topic><topic>Patients</topic><topic>Surgery</topic><topic>Thyroid cancer</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Weber, Kaare J., M.D</creatorcontrib><creatorcontrib>Solorzano, Carmen C., M.D</creatorcontrib><creatorcontrib>Lee, Jane K., M.D</creatorcontrib><creatorcontrib>Gaffud, Michael J., M.D</creatorcontrib><creatorcontrib>Prinz, Richard A., M.D</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>The American journal of surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Weber, Kaare J., M.D</au><au>Solorzano, Carmen C., M.D</au><au>Lee, Jane K., M.D</au><au>Gaffud, Michael J., M.D</au><au>Prinz, Richard A., M.D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Thyroidectomy remains an effective treatment option for Graves’ disease: reply</atitle><jtitle>The American journal of surgery</jtitle><date>2007-08-01</date><risdate>2007</risdate><volume>194</volume><issue>2</issue><spage>270</spage><epage>271</epage><pages>270-271</pages><issn>0002-9610</issn><eissn>1879-1883</eissn><abstract>Seven of our patients received postoperative radioiodine, 5 with a diagnosis of cancer and 2 with a diagnosis of ophthalmopathy. Because most of these patients are referred to us by an endocrinologist, some of the decision making about further radioiodine therapy reverts back to them because they provide ongoing follow-up evaluation and management.</abstract><cop>New York</cop><pub>Elsevier Inc</pub><doi>10.1016/j.amjsurg.2006.07.021</doi><tpages>2</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-9610 |
ispartof | The American journal of surgery, 2007-08, Vol.194 (2), p.270-271 |
issn | 0002-9610 1879-1883 |
language | eng |
recordid | cdi_proquest_journals_1444609479 |
source | Elsevier ScienceDirect Journals |
subjects | Cancer therapies Hormones Immune system Patients Surgery Thyroid cancer |
title | Thyroidectomy remains an effective treatment option for Graves’ disease: reply |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T00%3A09%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Thyroidectomy%20remains%20an%20effective%20treatment%20option%20for%20Graves%E2%80%99%20disease:%20reply&rft.jtitle=The%20American%20journal%20of%20surgery&rft.au=Weber,%20Kaare%20J.,%20M.D&rft.date=2007-08-01&rft.volume=194&rft.issue=2&rft.spage=270&rft.epage=271&rft.pages=270-271&rft.issn=0002-9610&rft.eissn=1879-1883&rft_id=info:doi/10.1016/j.amjsurg.2006.07.021&rft_dat=%3Cproquest_cross%3E3107756081%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1444609479&rft_id=info:pmid/&rft_els_id=S0002961007001468&rfr_iscdi=true |